Therapeutic induction of angiogenesis by direct myocardial administration of an adenovirus vector encoding human hepatocyte growth factor gene and its safety

Chinese Science Bulletin

Volumn 49, Issue 14, 2004, Pages 1464-1469

  Wu, Danli ^a   Zhang, Yourong ^a   Lao, Miaofen ^a   Yuan, Lizhen ^a   Wang, Lan ^a   Ha, Xiaoqin ^a   Wu, Zuze ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Gene therapy; Hepatocyte growth factor; Myocardial ischemia; Neutralizing antibody; Recombinant adenovirus

Indexed keywords

ADENOVIRIDAE;

EID: 33749664250     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1360/04wc0161     Document Type: Article

References (14)

1. Tio, R. A., Tkebuchava, T., Scheuermann, T. H. et al., Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium, Hum. Gene. Ther., 1999; 10(18): 2953-2960.
2. Hariawala, M. D., Horowitz, J. R., Esalof, D. et al., VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts, J. Surg. Res., 1996; 63(1): 77-82.
3. Carcia-Martinez, C., Opolon, P., Trochon, V. et al., Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor, Gene Ther., 1999, 6(7): 1210-1221.
4. Stuart, K. A., Riordan, S. M., Lidder, S. et al., Hepatocyte growth factor /scatter factor-induced intracellular signaling, Int. J. Exp. Pathol., 2000; 81(1): 17-30.
5. Vargas, G. A., Hoeflich, A., Jehle, P. M., Hepatocyte growth factor in renal failure: Promise and reality, Kidney Int., 2000, 57(4): 1426 -1436.
6. Moroshita, R., Aoki, M., Nakamura, S. et al., Gene therapy for cardiovascular disease using hepatocyte growth factor, Ann. N. Y. Acad, Sci., 2000, 902: 369-376.
7. Stella, M. C., Comoglio, P. M., HGF: A multifunctional growth factor controlling cell scattering, Int. J. Biochem. Cell Biol., 1999, 31(12): 1357-1362.
8. Wu Danli, Zhang Yourong, Lao Miaofen et al., Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene in rat myocardial ischemia models, Chinese Science Bulletin, 2003, 48(3): 273-276.
9. Tanaka, M., Brooks, S. E., Richard, V. J. et al., Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after 90 minutes of ischemia and 3 hours of reperfusion in dogs, Circulation, 1993, 87(2): 526-535.
10. Kowallik, P., Schulz, R., Guth, B. D. et al., Measurement of regional myocardial blood flow with multiple colored microspheres, Circulation, 1991, 83(3): 974-982.
11. Yasuda, S., Goto, Y., Baba, T. et al., Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function, J. Am. Coll. Cardiol., 2000, 36(1): 115-121.
12. Nakamura, T., Mizuno, S., Matsumoto, K. et al., Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF, J. Clin. Invest., 2000, 106(12): 1511-1519.
13. Simons, M., Annex, B., A double-blind, placebo-controlled, dose escalation phase I study to assess the safety and effects of AMG001 in patients with ischemic heart disease (IHD) not amenable to coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI), Recombinant DNA Advisory Committee, 2002, : 20-23.
14. Lee, L. Y., Patel, S. R., Hackett, N. R. et al., Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121, Ann. Thorac. Surg., 2000, 69(1): 14-24.